Xin Wang
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
- Lung Cancer Research Studies
Papers in
-
- Traditional Chinese Medicine Analysis 23
- Pharmacology 52
- Pharmacogenetics and Drug Metabolism 31
- Journals
- Biochemical Pharmacology (12 papers)Polyhedron (8 papers)Acta Pharmaceutica Sinica B (8 papers)Phytomedicine (8 papers)Toxicology Letters (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xin Wang
374 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Pharmacology 682
- Oncology 1.6k
- Complementary and alternative medicine 421
- Biochemistry 331
- Pharmaceutical Science 277
Countries citing papers authored by Xin Wang
This map shows the geographic impact of Xin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Wang more than expected).
Fields of papers citing papers by Xin Wang
This network shows the impact of papers produced by Xin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Wang. The network helps show where Xin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 21 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 37 | |
| 11 | CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia Hit paper breakdown → | 2022 | 109 |
| 12 | 2022 | 1 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 17 | |
| 16 | 2020 | 57 | |
| 17 | 2019 | 29 | |
| 18 | 2018 | 19 | |
| 19 | 2015 | 13 | |
| 20 | Research on Scavenging Effect of Chinese Herbal Medicine Extractive on Hydroxyl Free Radical by Photometry | 2012 | 3 |
About Xin Wang
Xin Wang is a scholar working on Complementary and alternative medicine, Pharmacology, Oncology, Biochemistry and Rheumatology, having authored 402 papers that have together received 8.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (39 papers), Lung Cancer Treatments and Mutations (33 papers), Pharmacogenetics and Drug Metabolism (31 papers), Traditional Chinese Medicine Analysis (23 papers), Cancer therapeutics and mechanisms (19 papers), Lung Cancer Research Studies (18 papers), Osteoarthritis Treatment and Mechanisms (18 papers) and Metal complexes synthesis and properties (16 papers). The work is most often cited by research in Pharmacology (682 citations), Oncology (1.6k citations), Complementary and alternative medicine (421 citations), Biochemistry (331 citations) and Pharmaceutical Science (277 citations). Xin Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mingyao Liu, Xuan Qin, Yuanjin Zhang, John H.K. Yeung, Jian Lu, Jian Lv, Wayne Lee, Penelope M.Y. Or, Yongmei Wang and Manohar Ratnam. Their work appears in journals such as Biochemical Pharmacology, Polyhedron, Acta Pharmaceutica Sinica B, Phytomedicine and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.